Translated title of the contribution | : Post-marketing analysis of peripheral neuropathy burden with new-generation proteasome inhibitors using the fda adverse event reporting system |
Mina, S. A.,
Muhsen, I. N.,
Burns, E. A.,
Sarfraz, H.,
Pingali, S. R.,
Xu, J. &
Hashmi, S. K.,
2021,
In: Turkish Journal of Hematology. 38,
3,
p. 218-221 4 p.Research output: Contribution to journal › Article › peer-review